Dialogue Health Technologies Inc.
Dialogue Health Technologies Inc. (DLHTF) Revenue
Annual & quarterly revenue history · segment & region breakdown
DLHTF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsDialogue Health Technologies Inc. trailing twelve-month (TTM) revenue is $0.09B, an increase of 28.04% year-over-year from $0.09B in FY2022.
Revenue trend
2022 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.09B | +$0.02B | +28.04% |
| 2021-12-31 | $0.07B | +$0.03B | +90.07% |
| 2020-12-31 | $0.04B | +$0.03B | +254.87% |
| 2019-12-31 | $0.01B | +$0.01B | +151.40% |
| 2018-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Dialogue Health Technologies Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Dialogue Health Technologies Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Dialogue Health Technologies Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DLHTF revenue · 4 questionsDLHTF's trailing twelve-month (TTM) revenue is $0.09B. That is an increase of 28.04% year-over-year from $0.09B in FY2022.
▸ Source: FMP · Dialogue Health Technologies Inc. SEC filings · GAAP · Dialogue Health Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026